Dyne Therapeutics Inc. (DYN)
12.10
-0.26 (-2.10%)
At close: Mar 13, 2025, 3:12 PM
Dyne Therapeutics Ratios Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
| PE Ratio | -6.99 | -3.36 | -3.65 | -4.05 | -5.15 | -80.2 | -51.29 | 50.94 | -2.49 | 59.75 | -44.95 | -6.71 | 27.47 | -1.77 | -12.26 | -19.12 | 119.50 | 159.33 |
| PEG Ratio | 0.48 | -0.14 | -0.43 | 0.14 | -0.00 | 2.22 | 0.26 | -0.49 | 0.00 | -0.34 | 0.53 | 0.01 | -0.26 | -0.00 | -0.22 | 0.03 | 3.58 | n/a |
| PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.65 | 2.26 | 3.55 | 2.05 | 796.67 | 796.67 | 1.84 | 1.23 | 9.78 | 5.86 | 13.56 |
| PB Ratio | 3.52 | 8.70 | 2.39 | 1.64 | 0.88 | 77.34 | -50.58 | 2.04 | 1.51 | 1.02 | 1.00 | 1.08 | 0.95 | 2.62 | 1.04 | 8.31 | 4.61 | 9.34 |
| P/FCF Ratio | -7.53 | -4.2 | -3.84 | -4.91 | -6.34 | -80.53 | -57.41 | 10.73 | 8.81 | -16.51 | -48.57 | 31.04 | -54.32 | -11.13 | 31.87 | 178.74 | 65.18 | 123.35 |
| P/OCF Ratio | -7.59 | -4.22 | -3.92 | -5.06 | -6.5 | -91.74 | -59.26 | 6.62 | 4.56 | 31.78 | -48.57 | 13.66 | -54.32 | -145.79 | 6.78 | 178.74 | 65.18 | 123.35 |
| OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.16 | 0.49 | 0.11 | -0.04 | 58.33 | -14.67 | -0.01 | 0.18 | 0.05 | 0.09 | 0.11 |
| Debt / Equity Ratio | 0.04 | 0.30 | 0.12 | 0.09 | n/a | n/a | -0.69 | 4.44 | 4.40 | 2.50 | 2.35 | 0.90 | 0.57 | 0.53 | 1.67 | 0.56 | 0.03 | 0.02 |
| Quick Ratio | 15.60 | 2.53 | 9.11 | 13.31 | 31.49 | 6.26 | 11.47 | 1.03 | 2.78 | 1.66 | 3.62 | 2.09 | 2.71 | 3.87 | 1.36 | 1.03 | 1.54 | 1.47 |
| Current Ratio | 15.60 | 2.53 | 9.11 | 13.31 | 31.49 | 6.26 | 11.47 | 1.45 | 3.26 | 2.40 | 3.93 | 2.34 | 3.01 | 4.23 | 1.43 | 1.10 | 1.65 | 1.66 |
| Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.04 | 0.10 | 0.07 | 0.13 | 0.00 | 0.00 | 0.38 | 0.23 | 0.23 | 0.25 | 0.23 |
| Interest Coverage | n/a | n/a | -58.61 | n/a | -148.1 | n/a | -959 | -0.67 | -1.02 | 0.12 | -4.75 | -3.28 | n/a | -0.66 | -0.03 | -2.01 | 1.66 | 1.58 |
| Return on Equity (ROE) | -0.5 | -2.58 | -0.65 | -0.41 | -0.17 | -0.96 | 0.99 | 0.04 | -0.61 | 0.02 | -0.02 | -0.16 | 0.03 | -1.48 | -0.09 | -0.43 | 0.04 | 0.06 |
| Return on Assets (ROA) | -0.46 | -1.43 | -0.54 | -0.35 | -0.17 | -0.82 | -0.58 | 0.01 | -0.09 | 0.00 | -0.01 | -0.07 | 0.02 | -0.4 | -0.02 | -0.12 | 0.01 | 0.02 |
| Return on Capital (ROIC) | -0.53 | -2.12 | -0.61 | -0.38 | -0.17 | -0.98 | -0.63 | -0.04 | -0.05 | 0.01 | -0.03 | -0.07 | 0.17 | -0.06 | -0.00 | -0.09 | 0.06 | 0.05 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -479.45% | -66.98% | -140.86% | 21.90% | -38.07K% | -8.83K% | 39.24% | 49.16% | 51.62% | 47.79% | 35.13% |
| Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15.02% | -90.78% | 5.94% | -4.57% | -11.87K% | 2.9K% | -103.79% | -10.07% | -51.13% | 4.90% | 8.51% |
| Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -106.32% | -94.36% | -50.71% | -18.28% | -13.9K% | 2.9K% | -143.66% | -10.12% | -54.9% | 6.93% | 8.60% |
| Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -81.42% | -46.85% | 7.60% | -21.69% | -10.6K% | 23.8K% | -14.89% | -0.47% | -33.79% | 19.98% | 19.50% |
| FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 71.34% | 25.62% | -21.5% | -4.23% | 2.57K% | -1.47K% | -16.53% | 3.87% | 5.47% | 8.99% | 10.99% |
| EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 187.55% | 7.76% | 87.41% | 19.92% | 5K% | 3.77K% | -99.31% | 31.60% | -7.01% | 25.42% | 26.75% |